Tagrid Antifungal

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Tagrid Antifungal
Generic name: TOLNAFTATE
Manufacturer: TAGRID LLC
Product type: HUMAN OTC DRUG
SPL set ID: 3663e054-9411-358a-e063-6394a90af6b4
SPL ID: 3695a809-1d6b-433d-92bf-1ea3b01a5c9e
Version: 3
Effective date: 2025-06-09
Source export date: 2026-09-28
Source partition: 14
Source file: https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:40:09

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Tagrid Antifungal	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		TAGRID LLC	openfda.manufacturer_name
ndc	package	85384-0010-1	openfda.package_ndc
ndc	product	85384-0010	openfda.product_ndc
ndc11	package	85384001001	derived:openfda.package_ndc
rxcui		1807715	openfda.rxcui
spl id		3695a809-1d6b-433d-92bf-1ea3b01a5c9e	id
spl set id		3663e054-9411-358a-e063-6394a90af6b4	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only Do not use on children under 2 years of age exceptunder the advice and supervision of a doctor. When using this product avoid contact with the eyes. Stop use and ask a doctor if irritation occurs or if there is no improvement within 2weeks for jock itch. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.